loader image
Sunday, February 23, 2025
44.2 F
McAllen
We Welcome your Press Release
- Advertisement -

ENDOVASCULAR  NEUROLOGIST  TO  SPEAK  ON  SPECIALIZED STROKE  TREATMENT  IN  McALLEN 

Breaking News
3422

Translate to Spanish or other 102 languages!

Mega Doctor News—

- Advertisement -

Dr. Ameer Hassan to Speak at Free “Dessert with the Doctor”

Tuesday, Nov. 11 at McAllen Public Library

McALLEN – Dr. Ameer Hassan, Endovascular Neurologist, will speak and answer questions on “Surviving a Stroke: Learn about Important Tools Available to Help Stop a Stroke from Progressing and Causing Permanent Disability”, during a free “Dessert with a Doctor” event on Tuesday, Nov. 11, at 6:30 p.m. at the McAllen Public Library, 4001 N. 23rd Street (just north of Nolana).   Dr. Hassan will also discuss specialized endovascular stroke treatment which can extend the window of time for care of stroke patients and reduce the chances of permanent disability.  The event is free and open to the public, and attendees are invited to enjoy a free heart-healthy dessert, compliments of Valley Baptist Medical Center.  For more information or to RSVP, please call 1-888-902-5433.

- Advertisement -

 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Unprecedented $10 million Federal Grant will boost the Valley
Next article
Foster, Cigarroa, Reyes in full support for Vaquero and President Guy Bailey

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

To be updated with all the latest news and special announcements.

Visits counter

Coming back soon...

This website debuted on 10/05/2013

© Mega Doctor News 2024

×